TY - JOUR
T1 - Recombinant ADAMTS-13
T2 - Goodbye, allergic reactions!
AU - Sarode, Ravi
N1 - Publisher Copyright:
© 2017 by The American Society of Hematology.
PY - 2017/11/9
Y1 - 2017/11/9
N2 - In this issue of Blood, Scully et al describe very promising results of a phase 1 study of recombinant ADAMTS-13 (rADAMTS-13; a disintegrin and metalloproteinase with thrombospondin type 1 motif, member 13) in patients with congenital thrombotic thrombocytopenic purpura (cTTP) that is likely to make these patients’ lives allergy free.1
AB - In this issue of Blood, Scully et al describe very promising results of a phase 1 study of recombinant ADAMTS-13 (rADAMTS-13; a disintegrin and metalloproteinase with thrombospondin type 1 motif, member 13) in patients with congenital thrombotic thrombocytopenic purpura (cTTP) that is likely to make these patients’ lives allergy free.1
UR - http://www.scopus.com/inward/record.url?scp=85033450634&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85033450634&partnerID=8YFLogxK
U2 - 10.1182/blood-2017-09-807164
DO - 10.1182/blood-2017-09-807164
M3 - Comment/debate
C2 - 29122768
AN - SCOPUS:85033450634
SN - 0006-4971
VL - 130
SP - 2045
EP - 2046
JO - Blood
JF - Blood
IS - 19
ER -